Endemic nephropathy: A disease that requires further research

Current Research in Balkan Endemic Nephropathy and Associated Urothelial Cancer

Balkan Endemic Nephropathy in Serbia: Current Status and Future Research

During the 90s, wars and economic hardship hampered most attempts for serious research in Serbia, as well as in other BEN affected countries. This relative lull in intensive research provided an opportunity for identifying key problems and assessing priorities for future research. The following issues were singled out as relevant from this point of view: 1. What is the trend of BEN? Did it disa...

Uddanam Nephropathy/Regional Nephropathy in India: Preliminary Findings and a Plea for Further Research.

Address correspondence to Anirban Ganguli, MD, Washington Hospital Center, 110 Irving St NW, Ste 2A70, Washington DC 20010. E-mail: [email protected] 2016 by the National Kidney Foundation, Inc. 0272-6386 http://dx.doi.org/10.1053/j.ajkd.2016.04.012 Even as chronic kidney disease (CKD) emerges as a global health problem, resource-constrained nations struggle to address this challenge due to ...

Membrane Research in a Global Context Requires Collaboration, not Competition!

Endemic (Balkan) nephropathy is aristolochic acid nephropathy.

Endemic nephropathy is a syndrome that comprises two entities: chronic interstitial nephropathy and urothelial cell cancers predominantly of the upper urinary tract. The etiological agent for the disease is aristolochic acid, a compound found in the plants of Aristolochia spp. The development of urothelial cancers is characterized by the formation of aristolactam DNA adducts leading to mutation...